Table 3.
Raw MF/SS-CTCL QoLa score | Scaled scoreb |
≤12c | 62 |
13 | 74 |
14 | 80 |
15 | 84 |
16 | 87 |
17 | 89 |
18 | 91 |
19 | 93 |
20 | 94 |
21 | 96 |
22 | 97 |
23 | 98 |
24 | 100 |
25 | 101 |
26 | 102 |
27 | 103 |
28 | 104 |
29 | 105 |
30 | 106 |
31 | 107 |
32 | 108 |
33 | 109 |
34 | 110 |
35 | 111 |
36 | 112 |
37 | 113 |
38 | 114 |
39 | 115 |
40 | 116 |
41 | 117 |
42 | 118 |
43 | 119 |
44 | 120 |
45 | 121 |
46 | 123 |
47 | 124 |
48 | 125 |
49 | 126 |
50 | 128 |
51 | 129 |
52 | 131 |
53 | 133 |
54 | 135 |
55 | 137 |
56 | 139 |
57 | 143 |
58 | 147 |
59-60 | 154 |
aMF/SS-CTCL: mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma quality of life.
bScaled scores were standardized on the current sample to have a mean of 100 and an SD of 15.
cWhile it is possible to obtain a raw score of 10 or 11 due to endorsing “Does not apply (I don’t have symptoms right now)” to MF/SS-CTCL QoL items, these scores should be viewed as equivalent to a 12.